Advertisement

Misonix, Inc. MSON

Set alert

Price alert · MSON

All alert types
26.54 0.00 0.00%

As of Apr 24, 3:47 PM ET

25.08 Day range 26.56

52-week range unavailable

Open
25.38
Prev close
26.54
Mkt cap
462.46M
Vol
157.17K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
25.08
High
26.56
Forward P/E
-42.81
Beta
1.35
Short ratio
3.26
Inst. own
40.97%
Dividend
0.00
Ex-div date
Earnings
Sep 2, 2021
50-d avg
25.71
200-d avg
23.51
1y target
28.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for MSON has not been loaded yet. Try again in a moment.

Key statistics

Market cap
462.46M
Enterprise value
478.22M
Trailing P/E
0.00
Forward P/E
-42.81
PEG ratio
-0.93
Price / sales
6.25
Price / book
3.42
EPS (TTM)
-0.84
Beta
1.35
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-19.55%
Revenue (TTM)
74.02M
Revenue growth
43.50%
Free cash flow
1.54M
Total cash
31.05M
Total debt
47.20M
Return on equity
-10.27%
Shares outstanding
17.43M
Short % of float
1.33%
50-day average
25.71
200-day average
23.51

Analyst view

Consensus: hold

Hold
Price target (mean) 28.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Sep 2, 2021

Expected Sep 2, 2021. Consensus EPS estimate -0.28.

Earnings history

Financials — quick view

All financials
MSON Revenue — quarterly 19.69M
2018-Q1 20172018-Q2 20172018-Q3 20182018-Q4 20182019-Q1 20182019-Q2 20182019-Q3 20192019-Q4 20192020-Q1 20192020-Q2 20192020-Q3 20202020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20212021-Q4 2021
MSON Net income — quarterly -4.47M
2018-Q1 20172018-Q2 20172018-Q3 20182018-Q4 20182019-Q1 20182019-Q2 20182019-Q3 20192019-Q4 20192020-Q1 20192020-Q2 20192020-Q3 20202020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20212021-Q4 2021
MSON EPS — quarterly -0.26
2018-Q1 20172018-Q2 20172018-Q3 20182018-Q4 20182019-Q1 20182019-Q2 20182019-Q3 20192019-Q4 20192020-Q1 20192020-Q2 20192020-Q3 20202020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20212021-Q4 2021

Earnings

MSON recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Sep 2, 2021Jun 1, 20210.00———
May 6, 2021Mar 1, 20210.00———
Feb 4, 2021Dec 1, 20200.00———
Nov 5, 2020Sep 1, 20200.00———
Sep 3, 2020Jun 1, 20200.00———
May 11, 2020Mar 1, 20200.00———

Upgrades / downgrades

MSON analyst upgrades and downgrades
DateFirmActionFromTo
Aug 2, 2021BTIGdownBuyNeutral
Jul 30, 2021Craig-HallumdownBuyHold
Jul 30, 2021Canaccord GenuitydownBuyHold
May 15, 2020Canaccord Genuitymain—Buy
Apr 3, 2020BTIGmain—Buy
Jun 12, 2019BTIG Researchinit—Buy

About Misonix, Inc.

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York. As of October 29, 2021, Misonix, Inc. operates as a subsidiary of Bioventus Inc.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
misonix.com

News

Your note

Sign in to keep a note on MSON — it syncs with the Stock Master app.

Insider holders

MSON insider holders
InsiderRelationLatest transactionDateShares held
BRENNAN JOSEPH JOfficerSaleFeb 10, 20195,292
DWYER JOSEPH PChief Financial OfficerPurchaseMar 8, 20204,700
KLUGEWICZ SHARON WChief Operating OfficerPurchaseMay 19, 20201,415
LUDECKER ROBERT SOfficerConversion of Exercise of derivative securityAug 26, 201811,500
MCBRAYER PATRICK ADirectorPurchaseFeb 11, 20181,100
MINER CHARLESIIIDirectorConversion of Exercise of derivative securityJun 25, 201829,382

Institution ownership

MSON institution ownership
Holder% heldSharesValueReported
Sv Health Investors, LLC9.73%1,694,01737.57MJun 29, 2021
Blackrock Inc.4.76%829,03818.39MJun 29, 2021
Royce & Associates LP4.42%769,05617.06MJun 29, 2021
Vanguard Group, Inc. (The)3.59%624,85413.86MJun 29, 2021
Pura Vida Investments, LLC2.71%472,21610.47MJun 29, 2021
Juniper Investment Company, LLC2.68%465,92010.33MJun 29, 2021

Fund ownership

MSON fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.09%363,3938.06MJun 29, 2021
iShares Russell 2000 ETF1.58%275,4076.97MSep 29, 2021
Pennsylvania Mutual Fund Inc1.16%201,2004.46MJun 29, 2021
Vanguard Extended Market Index Fund1.04%180,2344.00MJun 29, 2021
Royce Micro-Cap Fund0.90%157,2003.49MJun 29, 2021
Royce Opportunity Fund0.72%125,5562.78MJun 29, 2021
Advertisement